Evidence map›Paper›PMID 28842666›Full record

ArticleScientific reports2017

Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure.

Joe-Elie Salem, Florent Laveau, Alexandre Ceccaldi, Christian Funck-Brentano, Jean Sebastien Hulot, Amel Mameri, Olivier Barthelemy, Gerard Helft, Claude Le Feuvre, Richard Isnard and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joe-Elie SalemSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France. joe-elie.salem@aphp.fr.
Florent LaveauSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Alexandre CeccaldiSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Christian Funck-BrentanoSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.ORCID 0000-0003-0406-5189
Jean Sebastien HulotSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Amel MameriSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Olivier BarthelemySorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Gerard HelftSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Claude Le FeuvreSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Richard IsnardSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Nadjib HammoudiSorbonne Universités, UPMC Univ Paris 06, AP-HP, CIC 1421, CIC-Paris Est, Cardiology department-Echocardiography Unit, Pharmacology department, INSERM-U1166 ICAN, Pitié-Salpêtrière Hospital, F-75013, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ratio of early diastolic trans-mitral flow velocity to tissue-Doppler mitral annular early diastolic velocity (E/e'), and left ventricular end-diastolic pressure(LVEDP) have been shown to be correlated at rest, provided that patients are not on positive inotropic drugs. Data concerning the latter correlation during exercise stress are conflicting. Therefore, we investigated if use of negative inotropic drugs (NID), impacts the accuracy of E/e' as a surrogate for LVEDP during low-level exercise. An exercise(50 watts) during cardiac invasive hemodynamic monitoring and an exercise echocardiography were performed prospectively within 24 hours in 54 patients (81%male, 62 ± 9years) with preserved LV Ejection-Fraction. Before exercise, the patients had scattered LVEDP (13.8 ± 5.8 mmHg) and septal E/e' (8.7 ± 2.7). Half of them were on NID, mainly betablockers(n = 26). The correlation between septal-E/e' and LVEDP was low for examinations performed at rest (r = 0.35,p = 0.01) with no significant impact of NID. For measurements performed at 50 Watts, NID had a significant impact on the association between septal-E/e'50 watts and LVEDP50 watts (β = -0.28,p = 0.03). Correlation between septal-E/e'50 watts and LVEDP50 watts persisted in patients on NID (r = 0.61,p = 0.001) while it disappeared in the group of patients with no NID (r = 0.15,p = 0.47). NID use is an important confounding factor to take into consideration when assessing exercise LVFP using stress E/e' in patients with preserved LVEF.

Indexed as

Echocardiography, StressAdrenergic beta-AntagonistsAgedCalcium Channel BlockersData AnalysisDiastoleFemaleHeart Function TestsHemodynamicsHumansMaleMiddle AgedStroke VolumeVentricular Function, LeftVentricular PressureAdrenergic beta-AntagonistsCalcium Channel Blockers

Identifiers

PMID28842666
PMCPMC5573383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.